DailyDoctor Archive Specialties Get app
All pulmonology briefings

The edition · Pulmonology

Adaptive D-dimer cut-offs missed few PEs even in the 'grey zone' above 500

A meta-analysis of prospective management studies checks the patients these rules newly exclude. Also: most biologic-eligible asthma improved without a biologic, the case against widening lung screening on stage shift alone, and nasal NO to find PCD in bronchiectasis.

The edition in brief

Today's pulmonology edition closes on adaptive D-dimer thresholds for suspected pulmonary embolism. Pooling six prospective management studies of 12,194 patients, the three-month failure rate when PE was excluded without CT pulmonary angiography was 0.12% overall, and 0.50% (95% CI 0.20 to 1.11%) among patients whose D-dimer was above 500 ng/mL but below the age- or probability-adjusted cut-off. In 10,078 UK adults who first met biologic criteria for severe asthma, 70% improved to fewer than three exacerbations a year on standard care alone; a persistently frequent group had higher blood eosinophils years before eligibility. A Chest review argues that extending low-dose CT screening to people without a substantial smoking history, as in China, risks more overdiagnosis than benefit unless advanced-stage incidence falls. In 373 Chinese adults and adolescents with bronchiectasis, nasal nitric oxide screening identified primary ciliary dyskinesia in 7.4%, with sensitivity 84.8% and specificity 97.1%. The pearl covers what to check before calling asthma severe.

In this edition

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for pulmonology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free